Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis

• Váldodahkkit: Can Chen (Dahkki), Yuanqing Kan (Dahkki), Zhenyu Shi (Dahkki), Daqiao Guo (Dahkki), Weiguo Fu (Dahkki), Yanli Li (Dahkki), Qianzhou Lv (Dahkki), Xiaoyu Li (Dahkki), Yi Si (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: This study aims to explore the role of low-dose rivaroxaban (≤10 mg daily) for the treatment of atherosclerotic cardiovascular disease (ASCVD).Methods: PubMed, Embase and the Cochrane Library were searched for randomized controlled trials (RCTs) of low-dose rivaroxaban in patients with A...